Back to top
more

Owens & Minor (OMI)

(Delayed Data from NYSE)

$16.48 USD

16.48
1,898,347

+1.17 (7.64%)

Updated Jul 23, 2024 04:00 PM ET

After-Market: $16.48 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Urmimala Biswas headshot

4 MedTech Stocks Up More Than 100% in 2020 With Room to Run

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Zacks.com featured highlights include: AutoNation, Laboratory Corporation, OMI, TTEC and ArcBest

Zacks.com featured highlights include: AutoNation, Laboratory Corporation, OMI, TTEC and ArcBest

Agios (AGIO) to Sell Oncology Drugs to Servier for $2B, Stock Up

Agios (AGIO) sells its oncology business unit to French company Servier for around $2 billion. The company plans to solely focus on developing treatments for genetically defined diseases. Shares rise.

Swayta Shah headshot

Bet on These 5 Stocks With Upgraded Broker Ratings Right Now

After thorough research, brokers rate particular company's stock. So, we pick Hain Celestial (HAIN), Owens & Minor (OMI), Myers Industries (MYE), Owens Corning (OC) and Manpower (MAN) as these witness ratings upgrade.

Anirudha Bhagat headshot

6 Stocks Near 52-Week Highs That are Poised to Rally Further

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session

AtriCure (ATRC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Top Ranked Growth Stocks to Buy for December 21st

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 21st

Top Ranked Growth Stocks to Buy for December 16th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 16th.

Top Ranked Growth Stocks to Buy for December 14th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 14th.

Top Ranked Growth Stocks to Buy for December 11th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 11th

The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic

The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic

Is Owens & Minor (OMI) a Worthy Pick for Value Investors?

Let's see if Owens & Minor (OMI) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service

Zacks.com featured highlights include: Innoviva, Owens & Minor, Standard Motor Products, NIC and California Water Service

Trina Mukherjee headshot

4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021

Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.

Anirudha Bhagat headshot

6 Stocks Near 52-Week Highs Poised to Rally Further

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

Nilanjan Banerjee headshot

Buy These 5 Low-Beta Stocks to Combat a Choppy Market

To combat market volatility, it is of utmost importance to create a portfolio of low-beta stocks.

Top Ranked Growth Stocks to Buy for December 7th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 7th

Agios' (AGIO) Phase III Study on Mitapivat Meets Primary Goal

Agios' (AGIO) phase III ACTIVATE study evaluating mitapivat for addressing PK deficiency in patients with no regular blood transfusions achieves the primary goal.

Top Ranked Growth Stocks to Buy for December 2nd

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 2nd.

Top Ranked Growth Stocks to Buy for December 1st

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 1st.

Aniruddha Ganguly headshot

5 Top-Ranked Growth Stocks to Buy Instead of Bitcoin

Here we pick five stocks -- OMI, NLS, TTD, OSTK, FVRR -- that have surged more than 200% this year and are safer investment choices than cryptocurrencies.

New Strong Buy Stocks for November 27th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

Top Ranked Growth Stocks to Buy for November 27th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, November 27th

Sweta Killa headshot

10 Stocks That Deserve Thanks in Pandemic-Ravaged 2020

While the gains are broad based, we have highlighted 10 stocks - APPS, OMI, EXPI, TUP, STKL, CALX, VSTO, CMBM, QDEL and AVNW - that have been on the forefront of the rally this year.

Top Ranked Growth Stocks to Buy for November 20th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 20th